Outcome

This study demonstrates that low-pressure hyperbaric oxygen therapy (HBOT) significantly benefits women with fibromyalgia by reducing pain and improving their quality of life. By undergoing 40 sessions of HBOT over eight weeks participants showed notable improvements in self-perceived pain intensity pain catastrophism pain acceptance pain flexibility and mental defeat.

Introduction

Recent research has highlighted the effectiveness of low-pressure hyperbaric oxygen therapy (HBOT) in reducing pain and improving quality of life for women suffering from fibromyalgia a chronic condition characterized by widespread pain and reduced quality of life. In a randomized controlled trial involving 33 female participants those who received 40 sessions of HBOT over an 8-week period experienced significant improvements across various pain-related psychological constructs including pain intensity pain catastrophism pain acceptance pain flexibility and mental defeat. Additionally these participants reported marked enhancements in their overall quality of life. In contrast the control group which did not receive any treatment showed no improvements. These findings suggest that HBOT could serve as a promising therapeutic option for managing fibromyalgia-related pain and enhancing the well-being of women afflicted by this debilitating condition.

Results

The study evaluated the impact of low-pressure hyperbaric oxygen therapy (HBOT) on women with fibromyalgia focusing on psychological aspects related to pain and overall quality of life. Participants were subjected to 40 sessions of HBOT over eight weeks with each session lasting 90 minutes at 1.45 ATA pressure.

The findings were compelling: the HBOT group exhibited substantial improvements across all assessed pain-related psychological constructs. This included significant reductions in self-perceived pain intensity and pain catastrophism along with notable increases in pain acceptance and pain flexibility. Mental defeat related to pain also showed considerable improvement.

Moreover the participants in the HBOT group experienced marked enhancements in their overall quality of life. Conversely the control group which did not receive HBOT did not display any significant changes in these psychological or quality of life measures.

Statistical analyses revealed that the differences between the HBOT group and the control group were significant underscoring the treatment’s effectiveness in managing fibromyalgia-related pain and enhancing well-being. These results suggest that low-pressure HBOT could be a promising intervention for the management of fibromyalgia providing substantial relief from pain and improving the overall quality of life for sufferers.

Conclusion

In conclusion this study highlights the potential of low-pressure hyperbaric oxygen therapy (HBOT) as a viable treatment for managing fibromyalgia-related pain and enhancing quality of life in women. The significant improvements observed in pain intensity pain catastrophism pain acceptance pain flexibility and mental defeat among participants who underwent 40 sessions of HBOT over eight weeks underscore the therapy’s effectiveness. These benefits were notably absent in the control group reinforcing the positive impact of HBOT on psychological and pain-related constructs associated with fibromyalgia. The promising results suggest that HBOT could be integrated into therapeutic strategies for fibromyalgia offering meaningful relief and improved well-being for sufferers. Future research should further explore the long-term effects of HBOT and its potential applications in other chronic pain conditions to better understand the full scope of its therapeutic benefits.